Literature DB >> 27937087

Tailored Therapy for Stage I Non-Small-Cell Lung Cancer.

Calvin S H Ng1, Ze-Rui Zhao1, Rainbow W H Lau1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27937087     DOI： 10.1200/JCO.2016.70.4718

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  A complicated clinical problem: surgical treatment decisions for patients with early-stage lung cancer.

Authors:  Jianfei Shen; Yang Liu; Chengyang Dai; Baofu Chen; Chang Chen; Gaetano Rocco; Alessandro Brunelli; Chia-Chuan Liu; Rene Horsleben Petersen; Jianxing He
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Hybrid operating room-one stop for diagnosis, staging and treatment of early stage NSCLC.

Authors:  Joyce W Y Chan; Peter S Y Yu; Rainbow W H Lau; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2020-02       Impact factor: 2.895

Review 3.  Anaesthesiology for uniportal VATS: double lumen, single lumen and tubeless.

Authors:  Ze-Rui Zhao; Rainbow W H Lau; Calvin S H Ng
Journal:  J Vis Surg       Date:  2017-08-21

4.  Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.

Authors:  Chang Gu; Rui Wang; Xufeng Pan; Qingyuan Huang; Yangyang Zhang; Jun Yang; Jianxin Shi
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-17       Impact factor: 4.553

Review 5.  Catheter-based alternative treatment for early-stage lung cancer with a high-risk for morbidity.

Authors:  Ze-Rui Zhao; Rainbow W H Lau; Calvin S H Ng
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

6.  Mutation Profile of Resected EGFR-Mutated Lung Adenocarcinoma by Next-Generation Sequencing.

Authors:  Ze-Rui Zhao; Yao-Bin Lin; Calvin S H Ng; Rong Zhang; Xue Wu; Qiuxiang Ou; Wendan Chen; Wen-Jie Zhou; Yong-Bin Lin; Xiao-Dong Su; Yang W Shao; Hao Long
Journal:  Oncologist       Date:  2019-03-14

7.  Causes of death and competing risk analysis of the associated factors for non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database.

Authors:  Shenhai Wei; Jintao Tian; Xiaoping Song; Bingqun Wu; Limin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2017-10-04       Impact factor: 4.553

8.  Surgical modality for stage IA non-small cell lung cancer among the elderly: analysis of the Surveillance, Epidemiology, and End Results database.

Authors:  Weixi Wang; Yan Sun; Huiting Li; Minwei Bao; Xiaogang Liu; Gening Jiang; Cong Ye; Yu Hu
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.